Clinical Trials Directory

Trials / Completed

CompletedNCT05727137

Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty

Analgesic Efficacy of Daily Single Shot Adductor Canal Block Versus Continuous Adductor Canal Block After Total Knee Arthroplasty

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Seoul National University Hospital · Academic / Other
Sex
All
Age
19 Years – 75 Years
Healthy volunteers
Accepted

Summary

This study will compare the analgesic efficacy of daily single-shot adductor canal block(ABC) versus continuous ACB after total knee arthroplasty (TKA).

Detailed description

Patients 19-75 years old, of ASA classification I-III scheduled for unilateral TKA, will be enrolled and randomized into two groups, single-shot ACB group and continuous ACB group. In both groups, participants will be administered a single-shot ACB immediately after the end of the operation. The single-shot ACB group will receive two separate single-shot ACBs, on the first and second postoperative day. A nerve block catheter will be placed in patients in the continuous ACB group, which will be connected to a patient-controlled analgesia pump until the second postoperative day. The primary outcome of this study is the average NRS pain score at rest from the end of surgery to 2 days after surgery.

Conditions

Interventions

TypeNameDescription
PROCEDURESingle shot adductor canal blockSingle shot adductor canal block on the the first and second postoperative day.
PROCEDUREContinuous adductor canal blockA catheter will be placed in the adductor canal and connected to a continuous patient-controlled analgesia pump.

Timeline

Start date
2023-02-21
Primary completion
2023-10-27
Completion
2024-03-08
First posted
2023-02-14
Last updated
2024-04-12

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT05727137. Inclusion in this directory is not an endorsement.